GPSM1 and type 2 diabetes mellitus: The results of the present study suggest that part of the underlying molecular mechanism of the effect of a T2D susceptibility gene, GPSM1, on T2D and obesity progression is through macrophage inflammation, and suggest that targeting GPSM1 is could be an approach for the treatment of T2D and obesity.